The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Diagnostics Market Research Report 2025
Synopsis
Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor.
The global Colorectal Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics.
Report Scope
The Colorectal Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Segment by Type
FOB Tests
CTC Tests
CEA Tests
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor.
The global Colorectal Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics.
Report Scope
The Colorectal Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Segment by Type
FOB Tests
CTC Tests
CEA Tests
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 FOB Tests
1.2.3 CTC Tests
1.2.4 CEA Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics Market Perspective (2019-2030)
2.2 Colorectal Cancer Diagnostics Growth Trends by Region
2.2.1 Global Colorectal Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Diagnostics Market Dynamics
2.3.1 Colorectal Cancer Diagnostics Industry Trends
2.3.2 Colorectal Cancer Diagnostics Market Drivers
2.3.3 Colorectal Cancer Diagnostics Market Challenges
2.3.4 Colorectal Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics Revenue
3.4 Global Colorectal Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics Revenue in 2023
3.5 Colorectal Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Diagnostics Market Size (2019-2030)
6.2 North America Colorectal Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics Market Size (2019-2030)
7.2 Europe Colorectal Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.1.5 Biocept Recent Development
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Detail
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.2.5 Cancer Genetics Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Detail
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.3.5 Foundation Medicine Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Detail
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.4.5 Sysmex Corporation Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.5.5 Danaher Corporation Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Detail
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.6.5 Epigenomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Detail
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.8.5 Rosetta Genomics Recent Development
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Detail
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.9.5 Exact Science Corporation Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Detail
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024)
11.10.5 Pathway Genomics Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of FOB Tests
Table 3. Key Players of CTC Tests
Table 4. Key Players of CEA Tests
Table 5. Key Players of Others
Table 6. Global Colorectal Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Colorectal Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Colorectal Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnostics Market Share by Region (2019-2024)
Table 10. Global Colorectal Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Colorectal Cancer Diagnostics Market Share by Region (2025-2030)
Table 12. Colorectal Cancer Diagnostics Market Trends
Table 13. Colorectal Cancer Diagnostics Market Drivers
Table 14. Colorectal Cancer Diagnostics Market Challenges
Table 15. Colorectal Cancer Diagnostics Market Restraints
Table 16. Global Colorectal Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Colorectal Cancer Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Colorectal Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics as of 2023)
Table 19. Ranking of Global Top Colorectal Cancer Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Colorectal Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Colorectal Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Colorectal Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Colorectal Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Colorectal Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Colorectal Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Colorectal Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Colorectal Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Colorectal Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Colorectal Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Colorectal Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Colorectal Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Colorectal Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Biocept Company Detail
Table 49. Biocept Business Overview
Table 50. Biocept Colorectal Cancer Diagnostics Product
Table 51. Biocept Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 52. Biocept Recent Development
Table 53. Cancer Genetics Company Detail
Table 54. Cancer Genetics Business Overview
Table 55. Cancer Genetics Colorectal Cancer Diagnostics Product
Table 56. Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Cancer Genetics Recent Development
Table 58. Foundation Medicine Company Detail
Table 59. Foundation Medicine Business Overview
Table 60. Foundation Medicine Colorectal Cancer Diagnostics Product
Table 61. Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Foundation Medicine Recent Development
Table 63. Sysmex Corporation Company Detail
Table 64. Sysmex Corporation Business Overview
Table 65. Sysmex Corporation Colorectal Cancer Diagnostics Product
Table 66. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Sysmex Corporation Recent Development
Table 68. Danaher Corporation Company Detail
Table 69. Danaher Corporation Business Overview
Table 70. Danaher Corporation Colorectal Cancer Diagnostics Product
Table 71. Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Danaher Corporation Recent Development
Table 73. Epigenomics Company Detail
Table 74. Epigenomics Business Overview
Table 75. Epigenomics Colorectal Cancer Diagnostics Product
Table 76. Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Epigenomics Recent Development
Table 78. Illumina Company Detail
Table 79. Illumina Business Overview
Table 80. Illumina Colorectal Cancer Diagnostics Product
Table 81. Illumina Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Illumina Recent Development
Table 83. Rosetta Genomics Company Detail
Table 84. Rosetta Genomics Business Overview
Table 85. Rosetta Genomics Colorectal Cancer Diagnostics Product
Table 86. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Rosetta Genomics Recent Development
Table 88. Exact Science Corporation Company Detail
Table 89. Exact Science Corporation Business Overview
Table 90. Exact Science Corporation Colorectal Cancer Diagnostics Product
Table 91. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 92. Exact Science Corporation Recent Development
Table 93. Pathway Genomics Corporation Company Detail
Table 94. Pathway Genomics Corporation Business Overview
Table 95. Pathway Genomics Corporation Colorectal Cancer Diagnostics Product
Table 96. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Pathway Genomics Corporation Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Colorectal Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. FOB Tests Features
Figure 4. CTC Tests Features
Figure 5. CEA Tests Features
Figure 6. Others Features
Figure 7. Global Colorectal Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Colorectal Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Colorectal Cancer Diagnostics Report Years Considered
Figure 13. Global Colorectal Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Colorectal Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Colorectal Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Colorectal Cancer Diagnostics Market Share by Players in 2023
Figure 17. Global Top Colorectal Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics Revenue in 2023
Figure 19. North America Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Colorectal Cancer Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Colorectal Cancer Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Colorectal Cancer Diagnostics Market Share by Region (2019-2030)
Figure 33. China Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Colorectal Cancer Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Colorectal Cancer Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Colorectal Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 48. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 49. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 50. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 51. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 52. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 53. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 54. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 55. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 56. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
